PROPIKACIN

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H43N5O12
Molecular Weight	557.5924
Optical Activity	UNSPECIFIED
Defined Stereocenters	15 / 15
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](NC(CO)CO)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O

InChI

InChIKey=ZEFUFVWPRPISAD-FLUPTLLOSA-N

InChI=1S/C21H43N5O12/c22-2-9-14(31)15(32)12(25)20(35-9)37-18-7(23)1-8(26-6(3-27)4-28)19(17(18)34)38-21-16(33)11(24)13(30)10(5-29)36-21/h6-21,26-34H,1-5,22-25H2/t7-,8+,9+,10+,11-,12+,13+,14+,15+,16+,17-,18+,19-,20+,21+/m0/s1

HIDE SMILES / InChI

Description

Propikacin (also known as UK31214) is kanamycin B derivative patented by Pfizer Inc. as antibacterial compound. In preclinical studies Propikacin shows antibacterial activity against the Enterobacteriaceae, P. stuartii strains and the gentamicin-resistant strains of P. aeruginosa.

Originator

Approval Year

PubMed

Title	Date	PubMed
No data available in table

Patents

Show entries

Name

Type

Language

PROPIKACIN

Official Name

English

UK-31,214

Code

English

PROPIKACIN [USAN]

Common Name

English

UK-31214

Code

English

propikacin [INN]

Common Name

English

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Antibiotic

NCI_THESAURUS

C2363

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

SMS_ID

100000081357

PRIMARY

EVMPD

SUB10107MIG

PRIMARY

FDA UNII

9X6F5H479X

PRIMARY

INN

4850

PRIMARY

NCI_THESAURUS

C75063

PRIMARY

Showing 1 to 5 of 9 entries

Previous1 2Next

ACTIVE MOIETY


					9X6F5H479X

PROPIKACIN